-
Semaglutide Fatigue: Understanding and Overcoming This Common Side Effect
If you’re experiencing fatigue while taking Ozempic® (semaglutide), Wegovy®(semaglutide), or compounded semaglutide, you’re not alone. Learn how to manage this common side effect and maintain your energy levels. Fortunately, this fatigue is often temporary and manageable with […]
-
What To Eat On Semaglutide: Top Food Choices for Weight Loss and Health
Understanding what to eat while taking Ozempic® (semaglutide), Wegovy® (semaglutide), or compounded semaglutide is crucial for maximizing weight loss benefits. This guide will provide a comprehensive list of foods to eat while on semaglutide and highlight the […]
-
Comprehensive Weight Loss Programs at Ivím Health: Flexible Memberships with GLP-1 Medications and Klarna Payments
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Zepbound® (tirzepatide) and Compounded Tirzepatide Dosage Charts: A Comprehensive Guide
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
What Is Ivím Health’s Online Weight Loss Program Membership?
At Ivím Health, our mission is to deliver unparalleled, personalized care that goes far beyond basic healthcare—and our membership model allows us to do just that. We’re proud to offer so much more than just weight loss […]
-
Is Compounded Tirzepatide Safe? Understanding Safety and Side Effects
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Semaglutide Weight Loss Dosage Chart: Everything You Need to Know
The path to weight loss can often feel daunting, but a new medication called semaglutide is offering fresh optimism. Better known by brand names like Wegovy® and Ozempic®, semaglutide has demonstrated remarkable effectiveness in supporting weight management […]
-
Ivím Provider Completes Medical Mission Trip to Promote Health and Foster Community
At Ivím, our mission is to build health and foster community, not just within our own organization, but across the globe. We are proud to have dedicated providers like Arielle Gelardi, NP, who embody this mission through […]
-
Support for a Successful Weight Loss Transformation
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
The Benefits of Ozempic® (semaglutide) for Weight Loss
Initially developed as a treatment for type 2 diabetes, Ozempic® (semaglutide) has emerged as a transformative solution for weight loss. Semaglutide, the active ingredient in Ozempic®, has shown significant results in clinical trials. Research reveals that adults […]
-
GLP-1s and Nutrition: What You Need to Know
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Designing Your Weight Loss Journey Around Healthy Habits
While GLP-1 medication provides a phenomenal jumpstart for a weight loss journey, an integral part of achieving long-term results is developing healthy habits along the way. Diet and exercise are two common goals people set to improve, […]
-
Compound Medications for Weight Loss
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
The Landscape of Weight Loss Medications: An Overview
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Tirzepatide for Weight Loss
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Exercise and Its Role in Metabolic Weight Loss: Tips from the Clinic
Introduction to Metabolic Weight Loss Metabolic weight loss delves deeper than the surface-level concept of “calories in versus calories out” that’s often associated with traditional weight loss methods. Instead, it focuses on optimizing the body’s metabolic rate—the […]
-
Introduction to Semaglutide Compounded with B12
Introduction In the dynamic landscape of modern medicine, the practice of pharmaceutical compounding has found renewed relevance. This intricate process of tailoring medications isn’t just about mixing ingredients; it represents a holistic approach, aiming to customize treatments […]
-
The Benefits of Compounded Semaglutide for Weight Loss
Introduction to Compounded Semaglutide Compounded semaglutide, initially developed and introduced for the management of type 2 diabetes, has garnered significant attention in the medical community for its impressive efficacy. As a glucagon-like peptide-1 (GLP-1) receptor agonist, compounded semaglutide works […]
-
The Role of Tirzepatide Compounding Pharmacies in Personalized Weight Loss
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
The Role of a Weight Loss Prescription in Combating Obesity Epidemic
Introduction We live in a culture that is characterized by sedentary routines and a prevalence of high-calorie, easily accessible foods. Due to this, the obesity epidemic has emerged as a critical global issue. Its ramifications are far-reaching, […]
-
FAQs on Semaglutide Dosage for Weight Loss
Introduction to Semaglutide Semaglutide (the active ingredient in Wegovy® and Ozempic®) is a relatively newer addition to the arsenal of medications designed to manage metabolic conditions. It originated as a treatment for Type 2 diabetes and now […]
-
Introduction to Semaglutide Dosage
What is Semaglutide? Semaglutide (the active ingredient in Wegovy® and Ozempic®) is a revolutionary medication primarily developed for the management of type 2 diabetes. Now, it is an FDA approved treatment of obesity as well. As a […]
-
Finding the Right Online Prescription Weight Loss Specialist
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Combining GLP-1 weight loss with Diet and Exercise: A Powerful Weight Loss Strategy
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
The Rise of Online Weight Loss Programs: How Technology is Transforming the Fitness Industry
Introduction In recent years, we have witnessed a significant rise in the popularity of online weight loss programs. This is all thanks to the transformative power of technology in the fitness industry. Gone are the days when […]
-
The Rise of a Telemedicine Weight Loss Prescription
Introduction In recent years, the healthcare industry has witnessed a remarkable transformation with the introduction of telemedicine. It has revolutionized the landscape of weight loss prescriptions. Telemedicine, powered by technological advancements and fueled by the growing need […]
-
The Benefits of Choosing an Online Prescription Weight Loss Center
Introduction Online prescription weight loss centers have revolutionized the way we approach our health and wellness goals. With convenience and accessibility at the forefront, these centers provide personalized guidance, expert support, and comprehensive approaches to weight loss. […]
-
Mounjaro Weight Loss Prescription: Myth or Miracle?
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Understanding Metabolic Weight Loss: Exploring the Science Behind It
Introduction Metabolic weight loss has emerged as a popular approach to shedding unwanted pounds and achieving sustainable weight loss. Unlike traditional weight loss methods that focus solely on calorie restriction, metabolic weight loss emphasizes understanding the intricate […]
-
Semaglutide Dosing for Weight Loss: What You Need to Know
Introduction to Semaglutide Dosing Semaglutide (the active ingredient in Wegovy® and Ozempic®)[1] is a medication initially developed for the management of type 2 diabetes. Lately, it has emerged as a promising agent in the realm of weight […]
-
How an Online Weight Loss Prescription Can Change the Game
Introduction An online weight loss prescription has emerged as a convenient an accessible option for individuals seeking professional guidance in their weight loss journey. In recent years, these virtual platforms have gained significant popularity. Their convenience, ease […]
-
Mistakes to Avoid When Trying Mounjaro® Dosing for Weight Loss
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Why Choose Liraglutide?
Liraglutide (the active ingredient in Saxenda®)[1] and semaglutide (the active ingredient in Wegovy® and Ozempic®)[2] are both medications that belong to the same class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Saxenda® (liraglutide), Wegovy® (semaglutide) is […]
-
Benefits of Liraglutide
Obesity is a growing health concern worldwide, and it is associated with an increased risk of developing several chronic diseases, including type 2 diabetes, heart disease, and certain types of cancer. While diet and exercise are the […]
-
Semaglutide vs Liraglutide
Liraglutide (the active ingredient in Saxenda®)[1] and semaglutide (the active ingredient in Wegovy® and Ozempic®)[2] are two GLP-1 receptor agonists used to manage type 2 diabetes. The primary difference between the two GLP-1 medications is the dosage […]
-
Semaglutide FAQs
What is Semaglutide?Semaglutide (the active ingredient in Novo Nordisk’s Ozempic® and Wegovy® drug products)– is an injectable medication which, when used in combination with diet and exercise, helps with blood sugar control, appetite control, and potential weight […]
-
The Newly Approved “Game Changer” Weight Loss Drug
The most effective drug intervention for the treatment of obesity is now available and has acclaimed the label “weight loss wonder drug” and a “game changer” weight loss solution. In a recently published study in the New […]
-
What Is Semaglutide And How Does It Work?
Semaglutide (the active ingredient in Ozempic® and Wegovy®)[1] is an injectable medication which, when used in combination with diet and exercise, helps with blood sugar control, appetite control, and potential weight loss. Semaglutide belongs to a class of medications […]
New 6 & 12 month plans - Start for free today!
Services
Company
Support
Legal
